NCI

Value 20232024 TTM Total revenue 22.3 M30.34 M — Gross profit 4.49 M6.37 M — Operating expenses 2.92 M4.78 M — Selling/general/admin expenses 683.26 K931.12 K — Research & development —— — Operating income 1.16 M1.49 M — Non-Operating Income, Total -1.15 M-311.83 K — Interest expense, net of interest capitalized —— — Non-Operating Income, excl. Interest Expenses -725.43 K-329.11 K — Unusual income/expense -423.34 K17.28 K — Pretax income 734.85 K1.18 M — Equity in earnings —— — Taxes 169.65 K139.8 K — Non-controlling/minority interest —— — After tax other income/expense —— — Net income before discontinued operations 565.2 K1.04 M — Discontinued operations —— — Net income 565.2 K1.04 M — Dilution adjustment —— — Preferred dividends —— — Diluted net income available to common stockholders 565.2 K1.04 M — Basic earnings per share (Basic EPS) 0.150.25 — Diluted earnings per share (Diluted EPS) 0.050.25 — Average basic shares outstanding 3.6 M3.92 M — Diluted shares outstanding 3.6 M3.92 M — EBITDA 1.59 M1.86 M — EBIT 1.57 M1.58 M — Cost of revenue 17.82 M23.97 M — Other cost of goods sold 8 7743 036 — Depreciation & amortization (cash flow) 18.58 K278.97 K —